Randall L W Caudill insider trades: SCOLR Pharma (DDD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randall reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2008 | DDD | ↓ Sell | 39,526 | $1.00 | $40K | By Dunsford Hill Capital Partners | Mar 13, 2008 (2d) |
| Nov 16, 2007 | VXGN | ↑ Buy | 10,000 | $0.65 | $7K | Direct | Nov 19, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DDD insiders
Open-market trades in the last 12 months
About Randall L W Caudill's insider trades
Randall L W Caudill is a director at SCOLR Pharma (DDD). Since Nov 16, 2007, Randall has reported 1 open-market purchase worth $7K and 1 sale worth $40K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DDD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.